Relapsed Non Hodgkin Lymphoma Recruiting Phase 1 / 2 Trials for Venetoclax (DB11581)

IndicationStatusPhase
DBCOND0062858 (Relapsed Non Hodgkin Lymphoma)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03505944Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell LymphomaTreatment